Global Active Pharmaceutical Ingredients Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 161028
- Pages: 150
-
Format:
Summary
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The global Active Pharmaceutical Ingredients market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Synthetic APIs
Biotech APIs
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddys Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Active Pharmaceutical Ingredients of Research
1.1.1 Definition
1.1.2 Specifications of Active Pharmaceutical Ingredients
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Synthetic APIs Overview
1.2.1.2 Biotech APIs Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 CNS
1.3.1.2 Cardiovascular
1.3.1.3 Genitourinary/Hormonal Drugs
1.3.1.4 Respiratory
1.3.1.5 Rheumatology
1.3.1.6 Diabetes
1.3.1.7 Oncology
1.3.1.8 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Synthetic APIs Market Size 2018-2023
3.1.1.1 Global Synthetic APIs Market Size and Growth Rate 2018-2023
3.1.1.2 Global Synthetic APIs Market Size by Region 2018-2023
3.1.2 Biotech APIs Market Size 2018-2023
3.1.2.1 Global Biotech APIs Market Size and Growth Rate 2018-2023
3.1.2.2 Global Biotech APIs Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Synthetic APIs Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Synthetic APIs Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Synthetic APIs Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Biotech APIs Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Biotech APIs Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Biotech APIs Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 CNS Market Size 2018-2023
4.1.1.1 Global CNS Market Size and Growth Rate 2018-2023
4.1.1.2 Global CNS Market Size by Region 2018-2023
4.1.2 Cardiovascular Market Size 2018-2023
4.1.2.1 Global Cardiovascular Market Size and Growth Rate 2018-2023
4.1.2.2 Global Cardiovascular Market Size by Region 2018-2023
4.1.3 Genitourinary/Hormonal Drugs Market Size 2018-2023
4.1.3.1 Global Genitourinary/Hormonal Drugs Market Size and Growth Rate 2018-2023
4.1.3.2 Global Genitourinary/Hormonal Drugs Market Size by Region 2018-2023
4.1.4 Respiratory Market Size 2018-2023
4.1.4.1 Global Respiratory Market Size and Growth Rate 2018-2023
4.1.4.2 Global Respiratory Market Size by Region 2018-2023
4.1.5 Rheumatology Market Size 2018-2023
4.1.5.1 Global Rheumatology Market Size and Growth Rate 2018-2023
4.1.5.2 Global Rheumatology Market Size by Region 2018-2023
4.1.6 Diabetes Market Size 2018-2023
4.1.6.1 Global Diabetes Market Size and Growth Rate 2018-2023
4.1.6.2 Global Diabetes Market Size by Region 2018-2023
4.1.7 Oncology Market Size 2018-2023
4.1.7.1 Global Oncology Market Size and Growth Rate 2018-2023
4.1.7.2 Global Oncology Market Size by Region 2018-2023
4.1.8 Others Market Size 2018-2023
4.1.8.1 Global Others Market Size and Growth Rate 2018-2023
4.1.8.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 CNS Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global CNS Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global CNS Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Cardiovascular Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Cardiovascular Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Cardiovascular Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Genitourinary/Hormonal Drugs Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Genitourinary/Hormonal Drugs Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Genitourinary/Hormonal Drugs Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Respiratory Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Respiratory Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Respiratory Market Estimates and Forecasts by Region 2024E-2030F
4.2.5 Rheumatology Market Estimates and Forecasts 2024E-2030F
4.2.5.1 Global Rheumatology Market Forecasts and Growth Rate 2024E-2030F
4.2.5.2 Global Rheumatology Market Estimates and Forecasts by Region 2024E-2030F
4.2.6 Diabetes Market Estimates and Forecasts 2024E-2030F
4.2.6.1 Global Diabetes Market Forecasts and Growth Rate 2024E-2030F
4.2.6.2 Global Diabetes Market Estimates and Forecasts by Region 2024E-2030F
4.2.7 Oncology Market Estimates and Forecasts 2024E-2030F
4.2.7.1 Global Oncology Market Forecasts and Growth Rate 2024E-2030F
4.2.7.2 Global Oncology Market Estimates and Forecasts by Region 2024E-2030F
4.2.8 Others Market Estimates and Forecasts 2024E-2030F
4.2.8.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.8.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Active Pharmaceutical Ingredients Market Competition
7.1.1 Global Active Pharmaceutical Ingredients Market by Companies
7.1.2 Global Active Pharmaceutical Ingredients Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Teva
8.1.1 Teva Company Profile
8.1.2 Teva Product Portfolio
8.1.3 Teva Business Performance
8.1.4 Teva Development Overview
8.2 Mylan
8.2.1 Mylan Company Profile
8.2.2 Mylan Product Portfolio
8.2.3 Mylan Business Performance
8.2.4 Mylan Development Overview
8.3 DSM
8.3.1 DSM Company Profile
8.3.2 DSM Product Portfolio
8.3.3 DSM Business Performance
8.3.4 DSM Development Overview
8.4 Aurobindo Pharma
8.4.1 Aurobindo Pharma Company Profile
8.4.2 Aurobindo Pharma Product Portfolio
8.4.3 Aurobindo Pharma Business Performance
8.4.4 Aurobindo Pharma Development Overview
8.5 Aspen
8.5.1 Aspen Company Profile
8.5.2 Aspen Product Portfolio
8.5.3 Aspen Business Performance
8.5.4 Aspen Development Overview
8.6 Novartis
8.6.1 Novartis Company Profile
8.6.2 Novartis Product Portfolio
8.6.3 Novartis Business Performance
8.6.4 Novartis Development Overview
8.7 BASF
8.7.1 BASF Company Profile
8.7.2 BASF Product Portfolio
8.7.3 BASF Business Performance
8.7.4 BASF Development Overview
8.8 Pfizer
8.8.1 Pfizer Company Profile
8.8.2 Pfizer Product Portfolio
8.8.3 Pfizer Business Performance
8.8.4 Pfizer Development Overview
8.9 Huahai Pharmaceutical
8.9.1 Huahai Pharmaceutical Company Profile
8.9.2 Huahai Pharmaceutical Product Portfolio
8.9.3 Huahai Pharmaceutical Business Performance
8.9.4 Huahai Pharmaceutical Development Overview
8.10 Hisun Pharmaceutical
8.10.1 Hisun Pharmaceutical Company Profile
8.10.2 Hisun Pharmaceutical Product Portfolio
8.10.3 Hisun Pharmaceutical Business Performance
8.10.4 Hisun Pharmaceutical Development Overview
8.11 Sun Pharmaceutical Industries
8.11.1 Sun Pharmaceutical Industries Company Profile
8.11.2 Sun Pharmaceutical Industries Product Portfolio
8.11.3 Sun Pharmaceutical Industries Business Performance
8.11.4 Sun Pharmaceutical Industries Development Overview
8.12 Zhejiang Medicine
8.12.1 Zhejiang Medicine Company Profile
8.12.2 Zhejiang Medicine Product Portfolio
8.12.3 Zhejiang Medicine Business Performance
8.12.4 Zhejiang Medicine Development Overview
8.13 Dr. Reddys Laboratories
8.13.1 Dr. Reddys Laboratories Company Profile
8.13.2 Dr. Reddys Laboratories Product Portfolio
8.13.3 Dr. Reddys Laboratories Business Performance
8.13.4 Dr. Reddys Laboratories Development Overview
8.14 Zhejiang NHU
8.14.1 Zhejiang NHU Company Profile
8.14.2 Zhejiang NHU Product Portfolio
8.14.3 Zhejiang NHU Business Performance
8.14.4 Zhejiang NHU Development Overview
8.15 Bayer
8.15.1 Bayer Company Profile
8.15.2 Bayer Product Portfolio
8.15.3 Bayer Business Performance
8.15.4 Bayer Development Overview
8.16 NCPC
8.16.1 NCPC Company Profile
8.16.2 NCPC Product Portfolio
8.16.3 NCPC Business Performance
8.16.4 NCPC Development Overview
8.17 AbbVie
8.17.1 AbbVie Company Profile
8.17.2 AbbVie Product Portfolio
8.17.3 AbbVie Business Performance
8.17.4 AbbVie Development Overview
8.18 Shandong Xinhua Pharmaceutical
8.18.1 Shandong Xinhua Pharmaceutical Company Profile
8.18.2 Shandong Xinhua Pharmaceutical Product Portfolio
8.18.3 Shandong Xinhua Pharmaceutical Business Performance
8.18.4 Shandong Xinhua Pharmaceutical Development Overview
8.19 Northeast Pharm
8.19.1 Northeast Pharm Company Profile
8.19.2 Northeast Pharm Product Portfolio
8.19.3 Northeast Pharm Business Performance
8.19.4 Northeast Pharm Development Overview
8.20 Harbin Pharmaceutical
8.20.1 Harbin Pharmaceutical Company Profile
8.20.2 Harbin Pharmaceutical Product Portfolio
8.20.3 Harbin Pharmaceutical Business Performance
8.20.4 Harbin Pharmaceutical Development Overview
8.21 LKPC
8.21.1 LKPC Company Profile
8.21.2 LKPC Product Portfolio
8.21.3 LKPC Business Performance
8.21.4 LKPC Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
